Do analysts rate DLXY or MWYN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delixy 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Marwynn 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, DLXY or MWYN?

Marwynn has lower revenue, but higher earnings than Delixy. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delixy $307.75M 0.03 -$4.46M N/A N/A Marwynn $11.81M 1.85 -$4.40M -$0.50 N/A

Is DLXY or MWYN more profitable?

Delixy has a net margin of 0.00% compared to Marwynn's net margin of -121.92%. Delixy's return on equity of 0.00% beat Marwynn's return on equity. Company Net Margins Return on Equity Return on Assets Delixy N/A N/A N/A Marwynn -121.92% -244.66% -72.88%

Does the media favor DLXY or MWYN?

In the previous week, Delixy had 1 more articles in the media than Marwynn. MarketBeat recorded 3 mentions for Delixy and 2 mentions for Marwynn. Marwynn's average media sentiment score of 0.93 beat Delixy's score of 0.30 indicating that Marwynn is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delixy 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Marwynn 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer DLXY or EPSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delixy 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Epsium Enterprise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, DLXY or EPSM?

Epsium Enterprise has lower revenue, but higher earnings than Delixy. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delixy $307.75M 0.03 -$4.46M N/A N/A Epsium Enterprise $5.12M 3.41 -$1.50M N/A N/A

Is DLXY or EPSM more profitable?

Company Net Margins Return on Equity Return on Assets Delixy N/A N/A N/A Epsium Enterprise N/A N/A N/A

Does the media prefer DLXY or EPSM?

In the previous week, Delixy and Delixy both had 3 articles in the media. Epsium Enterprise's average media sentiment score of 0.60 beat Delixy's score of 0.30 indicating that Epsium Enterprise is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delixy 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Epsium Enterprise 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate DLXY or NHTC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delixy 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Natural Health Trends 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, DLXY or NHTC?

Natural Health Trends has lower revenue, but higher earnings than Delixy. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delixy $307.75M 0.03 -$4.46M N/A N/A Natural Health Trends $39.78M 0.33 -$880K -$0.11 N/A

Do analysts prefer DLXY or SCNX?

Scienture has a consensus target price of $1.50, indicating a potential upside of 316.44%. Given Scienture's stronger consensus rating and higher probable upside, analysts plainly believe Scienture is more favorable than Delixy. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delixy 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Scienture 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, DLXY or SCNX?

Delixy has higher revenue and earnings than Scienture. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delixy $307.75M 0.03 -$4.46M N/A N/A Scienture $430K 34.03 -$41.51M -$2.51 N/A

Is DLXY or SCNX more profitable?

Delixy's return on equity of 0.00% beat Scienture's return on equity. Company Net Margins Return on Equity Return on Assets Delixy N/A N/A N/A Scienture N/A -56.28% -44.76%

Does the media prefer DLXY or SCNX?

In the previous week, Delixy and Delixy both had 3 articles in the media. Scienture's average media sentiment score of 0.93 beat Delixy's score of 0.30 indicating that Scienture is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delixy 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Scienture 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend DLXY or CLWT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delixy 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Euro Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, DLXY or CLWT?

Euro Tech has lower revenue, but higher earnings than Delixy. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delixy $307.75M 0.03 -$4.46M N/A N/A Euro Tech $13.27M 0.85 $160K N/A N/A

Is DLXY or CLWT more profitable?

Company Net Margins Return on Equity Return on Assets Delixy N/A N/A N/A Euro Tech N/A N/A N/A

Delixy (DLXY) Competitors

$0.49 0.00 (-0.45%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$0.47 -0.02 (-3.44%)

As of 06/26/2026 07:59 PM Eastern

Compare

DLXY vs. MWYN, EPSM, NHTC, SCNX, and CLWT

Should you buy Delixy stock or one of its competitors? MarketBeat compares Delixy with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Delixy include Marwynn (MWYN), Epsium Enterprise (EPSM), Natural Health Trends (NHTC), Scienture (SCNX), and Euro Tech (CLWT). These companies are all part of the "wholesale" industry.

How does Delixy compare to Marwynn?

Delixy (NASDAQ:DLXY) and Marwynn (NASDAQ:MWYN) are both small-cap wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

Marwynn has lower revenue, but higher earnings than Delixy.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delixy	$307.75M	0.03	-$4.46M	N/A	N/A
Marwynn	$11.81M	1.85	-$4.40M	-$0.50	N/A

Delixy has a net margin of 0.00% compared to Marwynn's net margin of -121.92%. Delixy's return on equity of 0.00% beat Marwynn's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delixy	N/A	N/A	N/A
Marwynn	-121.92%	-244.66%	-72.88%

In the previous week, Delixy had 1 more articles in the media than Marwynn. MarketBeat recorded 3 mentions for Delixy and 2 mentions for Marwynn. Marwynn's average media sentiment score of 0.93 beat Delixy's score of 0.30 indicating that Marwynn is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delixy	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Marwynn	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delixy	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Marwynn	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Delixy beats Marwynn on 5 of the 8 factors compared between the two stocks.

How does Delixy compare to Epsium Enterprise?

Delixy (NASDAQ:DLXY) and Epsium Enterprise (NASDAQ:EPSM) are both small-cap wholesale companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

In the previous week, Delixy and Delixy both had 3 articles in the media. Epsium Enterprise's average media sentiment score of 0.60 beat Delixy's score of 0.30 indicating that Epsium Enterprise is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delixy	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Epsium Enterprise	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delixy	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Epsium Enterprise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Epsium Enterprise has lower revenue, but higher earnings than Delixy.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delixy	$307.75M	0.03	-$4.46M	N/A	N/A
Epsium Enterprise	$5.12M	3.41	-$1.50M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Delixy	N/A	N/A	N/A
Epsium Enterprise	N/A	N/A	N/A

Summary

Epsium Enterprise beats Delixy on 3 of the 4 factors compared between the two stocks.

How does Delixy compare to Natural Health Trends?

Delixy (NASDAQ:DLXY) and Natural Health Trends (NASDAQ:NHTC) are both small-cap wholesale companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

In the previous week, Delixy had 2 more articles in the media than Natural Health Trends. MarketBeat recorded 3 mentions for Delixy and 1 mentions for Natural Health Trends. Natural Health Trends' average media sentiment score of 1.90 beat Delixy's score of 0.30 indicating that Natural Health Trends is being referred to more favorably in the news media.

Company	Overall Sentiment
Delixy	Neutral
Natural Health Trends	Very Positive

10.1% of Natural Health Trends shares are held by institutional investors. 12.9% of Natural Health Trends shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Natural Health Trends has lower revenue, but higher earnings than Delixy.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delixy	$307.75M	0.03	-$4.46M	N/A	N/A
Natural Health Trends	$39.78M	0.33	-$880K	-$0.11	N/A

Delixy has a net margin of 0.00% compared to Natural Health Trends' net margin of -3.03%. Delixy's return on equity of 0.00% beat Natural Health Trends' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delixy	N/A	N/A	N/A
Natural Health Trends	-3.03%	-4.88%	-2.94%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delixy	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Natural Health Trends	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Delixy and Natural Health Trends tied by winning 5 of the 10 factors compared between the two stocks.

How does Delixy compare to Scienture?

Delixy (NASDAQ:DLXY) and Scienture (NASDAQ:SCNX) are both small-cap wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

Delixy's return on equity of 0.00% beat Scienture's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delixy	N/A	N/A	N/A
Scienture	N/A	-56.28%	-44.76%

In the previous week, Delixy and Delixy both had 3 articles in the media. Scienture's average media sentiment score of 0.93 beat Delixy's score of 0.30 indicating that Scienture is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delixy	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Scienture	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Scienture has a consensus target price of $1.50, indicating a potential upside of 316.44%. Given Scienture's stronger consensus rating and higher probable upside, analysts plainly believe Scienture is more favorable than Delixy.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delixy	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Scienture	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Delixy has higher revenue and earnings than Scienture.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delixy	$307.75M	0.03	-$4.46M	N/A	N/A
Scienture	$430K	34.03	-$41.51M	-$2.51	N/A

5.7% of Scienture shares are held by institutional investors. 21.4% of Scienture shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Scienture beats Delixy on 7 of the 11 factors compared between the two stocks.

How does Delixy compare to Euro Tech?

Delixy (NASDAQ:DLXY) and Euro Tech (NASDAQ:CLWT) are both small-cap wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

2.9% of Euro Tech shares are owned by institutional investors. 79.0% of Euro Tech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delixy	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Euro Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Delixy had 1 more articles in the media than Euro Tech. MarketBeat recorded 3 mentions for Delixy and 2 mentions for Euro Tech. Euro Tech's average media sentiment score of 0.44 beat Delixy's score of 0.30 indicating that Euro Tech is being referred to more favorably in the news media.

Company	Overall Sentiment
Delixy	Neutral
Euro Tech	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Delixy	N/A	N/A	N/A
Euro Tech	N/A	N/A	N/A

Euro Tech has lower revenue, but higher earnings than Delixy.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delixy	$307.75M	0.03	-$4.46M	N/A	N/A
Euro Tech	$13.27M	0.85	$160K	N/A	N/A

Summary

Euro Tech beats Delixy on 5 of the 7 factors compared between the two stocks.

Get Delixy News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DLXY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DLXY vs. The Competition

Export

Metric	Delixy	Wholesale – Petroleum And Petroleum Products Industry	Retail Sector	NASDAQ Exchange
Market Cap	$8.01M	$17.78M	$26.23B	$12.22B
Dividend Yield	N/A	N/A	175.37%	6.13%
P/E Ratio	N/A	N/A	20.88	24.18
Price / Sales	0.03	0.07	2.21	109.71
Price / Cash	N/A	N/A	14.74	54.37
Price / Book	48.78	25.72	6.23	6.35
Net Income	-$4.46M	-$3.11M	$962.92M	$337.74M
7 Day Performance	26.67%	17.70%	1.56%	0.09%
1 Month Performance	1.31%	8.84%	2.13%	-0.13%
1 Year Performance	N/A	N/A	2.39%	27.58%

Delixy Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DLXY Delixy	0.3401 of 5 stars	$0.49 -0.4%	N/A	N/A	$8.01M	$307.75M	N/A	N/A	News Coverage Short Interest Increase Gap Down
MWYN Marwynn	0.9558 of 5 stars	$1.03 -0.4%	N/A	-46.5%	$20.72M	$11.10M	N/A	27	News Coverage Analyst Forecast
EPSM Epsium Enterprise	0.5082 of 5 stars	$1.36 flat	N/A	-94.1%	$18.28M	$5.12M	N/A	13	News Coverage Analyst Forecast Short Interest Increase
NHTC Natural Health Trends	1.5515 of 5 stars	$1.82 flat	N/A	-64.3%	$15.62M	$39.78M	N/A	140	Positive News
SCNX Scienture	2.8289 of 5 stars	$0.38 flat	$1.50 +292.9%	-63.2%	$15.51M	$430K	N/A	N/A	Analyst Forecast Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DLXY) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Delixy (DLXY) Competitors